Zhou, Wei http://orcid.org/0000-0001-7719-0859
Zhao, Zhangchen http://orcid.org/0000-0002-7990-2589
Nielsen, Jonas B. http://orcid.org/0000-0002-6654-2852
Fritsche, Lars G. http://orcid.org/0000-0002-2110-1690
LeFaive, Jonathon http://orcid.org/0000-0003-3668-6086
Gagliano Taliun, Sarah A. http://orcid.org/0000-0003-1306-1868
Bi, Wenjian
Gabrielsen, Maiken E.
Daly, Mark J.
Neale, Benjamin M. http://orcid.org/0000-0003-1513-6077
Hveem, Kristian
Abecasis, Goncalo R.
Willer, Cristen J. http://orcid.org/0000-0001-5645-4966
Lee, Seunggeun http://orcid.org/0000-0002-8097-3878
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01 HG008773, T32HG010464, R01 HG008773)
Article History
Received: 20 March 2019
Accepted: 31 March 2020
First Online: 18 May 2020
Competing interests
: G.R.A. is an employee of Regeneron Pharmaceuticals. He owns stock and stock options for Regeneron Pharmaceuticals. B.M.N. is a member of the Deep Genomics Scientific Advisory Board, has received travel expenses from Illumina and also serves as a consultant for Avanir and Trigeminal solutions.